[1]
Bal, T. and Cabalak, M. 2021. Sofosbuvir and Ribavirin in Turkish non-cirrhotic chronic hepatitis C patients infected with genotype 2 or 3 . Annals of Medical Research. 27, 8 (May 2021), 2067–2071.